ABI, Agilent, NJMRC, Gen-Probe, Digene, Qiagen, Sigma-Aldrich, Affymetrix, HealthCare, Illumina, Veridex, Becton Dickinson | GenomeWeb
ABI to Accelerate Launch of Sequencer, Posts 7 Percent Revenue Gain for Q4
Applied Biosystems this week said that it is accelerating by at least three months the formal launch of its SOLiD next-generation DNA sequencer.
The company also said that fiscal fourth-quarter revenues rose 7 percent as R&D spending surged 15.6 percent and profit grew 14.5 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.